503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
0.11%
Revenue growth below 50% of CRWV's 23.55%. Michael Burry would check for competitive disadvantage risks.
-1.94%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
0.60%
Gross profit growth below 50% of CRWV's 25.15%. Michael Burry would check for structural issues.
0.49%
Margin expansion below 50% of CRWV's 1.30%. Michael Burry would check for structural issues.
11.07%
R&D change of 11.07% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
-100.00%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
-100.00%
Marketing expense reduction while CRWV shows 248.84% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
17.99%
Similar operating expenses growth to CRWV's 17.97%. Walter Schloss would investigate norms.
10.95%
Total costs growth 50-75% of CRWV's 18.28%. Bruce Berkowitz would examine efficiency.
No Data
No Data available this quarter, please select a different quarter.
142.57%
D&A growth above 1.5x CRWV's 26.15%. Michael Burry would check for excessive investment.
-1.97%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
37.21%
EBITDA margin growth exceeding 1.5x CRWV's 7.69%. David Dodd would verify competitive advantages.
-12.86%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-12.95%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-186.68%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-44.29%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-44.35%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-44.25%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-44.30%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-44.36%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-44.00%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-48.00%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-0.01%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.72%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.